Related Experiment Video
Updated: Jul 3, 2026

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Hippocampal C5a-C5aR1 axis drives age-related memory decline via collapsing synaptic chloride homeostasis
Wenying Liu1, Wei Qin2, Ying Li2
1Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing 100053, PR China.
Insights
The aging brain
Area of Science:
- Neuroscience
- Aging Research
- Neuroinflammation
Background:
- The hippocampus is vulnerable to aging and neuroinflammation, impacting plasticity.
- The complement C5a-C5aR1 axis is a key inflammatory pathway affecting synaptic function.
- Age-related dysregulation of the C5a-C5aR1 axis in the brain is not well understood.
Purpose of the Study:
- To characterize age-dependent changes in the hippocampal C5a-C5aR1 axis.
- To investigate the role of this axis in age-related memory decline.
Main Methods:
- Analysis of human plasma C5a levels and brain C5aR1 expression.
- Stereotaxic injection of C5a in young mice.
- Whole-cell patch-clamp recordings in primary hippocampal neurons.
- Treatment with C5aR1 antagonist PMX205 in senescence-accelerated mice.
Main Results:
- Aberrant activation of the C5a-C5aR1 pathway in aging.
- Elevated plasma C5a correlated with poorer memory in humans.
- C5a induced aging phenotypes, upregulated senescence markers, and decreased KCC2/NKCC1 ratio, suppressing inhibitory currents.
- PMX205 treatment attenuated memory decline and restored KCC2 expression.
Conclusions:
- C5a-induced memory decline results from disrupted synaptic chloride homeostasis.
- C5aR1 hyperactivation drives GABAergic dysfunction and neuronal hyperexcitability.
- C5aR1 is a potential therapeutic target for age-related cognitive decline and synaptic deterioration.
Abstract:
The hippocampus is highly vulnerable to brain aging and associated neuroinflammation, a key factor compromising hippocampal plasticity. Specifically, the complement C5a-C5aR1 axis acts as a critical inflammatory convergence point known to impair synaptic function. However, the specific dysregulation of this axis in the aging brain remains poorly understood. In this study, we aimed to characterize the age-dependent dynamics of the hippocampal C5a-C5aR1 axis and investigate its role in age-related memory decline. Our results revealed that the C5a-C5aR1 pathway is aberrantly activated during aging. In human cohorts, elevated plasma C5a levels correlated inversely with memory function, alongside increased C5aR1 expression in aged brains. Additionally, using stereotaxic injection of C5a in young mice and whole-cell patch-clamp recordings in primary hippocampal neurons, we demonstrated that C5a elicited robust brain aging phenotypes, upregulated senescence-associated secretory phenotype markers, and decreased the KCC2/NKCC1 chloride transporter ratio, leading to the suppression of spontaneous inhibitory postsynaptic currents (sIPSCs). These pathological synaptic changes and subsequent spatial memory decline were attenuated following treatment with the specific C5aR1 antagonist PMX205 in senescence-accelerated (SAMP8) mice, which effectively restored KCC2 expression. Our findings suggest that C5a-induced memory decline is driven by the collapse of synaptic chloride homeostasis, highlighting the role of C5aR1 hyperactivation as a crucial driver of GABAergic dysfunction and neuronal hyperexcitability. These results support C5aR1 as a promising therapeutic target for mitigating synaptic deterioration and preserving memory function in the aging brain.
Related Concept Videos
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Role of Hippocampus in Memory
Alzheimer Disease ll: Pathophysiology
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Alzheimer Disease l: Introduction

